Home > Insider Trading > Filing (0001209191-23-050864)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492674	T2 Biosystems Inc.	TTOO	Surgical & Medical Instruments & Apparatus (3841)	204827488

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1637591	L.p. Iii Partners Crg	1000 Main Street, Suite 2500 Houston TX 77002	No	No	Yes	No
1651357	L.p. (A) Fund Parallel - Iii Partners Crg	1000 Main Street, Suite 2500 Houston TX 77002	No	No	Yes	No
1702352	L.p. Group Cr	1000 Main Street, Suite 2500 Houston TX 77002	No	No	Yes	No
1767509	L.p. I Aiv Lev (Cayman) Iii Partners Crg	1000 Main Street, Suite 2500 Houston TX 77002	No	No	Yes	No
1767510	L.p. I Aiv Unlev (Cayman) Iii Partners Crg	1000 Main Street, Suite 2500 Houston TX 77002	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-09-27	2,391,981	$0.19	2,858,980	No	4	S	Indirect	By CRG Partners III L.P.
Common Stock	Disposition	2023-09-27	1,489,512	$0.19	1,780,317	No	4	S	Indirect	By CRG Partners III ? Parallel Fund ?A? L.P.
Common Stock	Disposition	2023-09-27	478,396	$0.19	571,796	No	4	S	Indirect	By CRG Partners III (Cayman) Unlev AIV I L.P.
Common Stock	Disposition	2023-09-27	1,621,313	$0.19	1,937,852	No	4	S	Indirect	By CRG Partners III (Cayman) Lev AIV I L.P.
Common Stock	Disposition	2023-09-28	2,858,980	$0.16	0	No	4	S	Indirect	By CRG Partners III L.P.
Common Stock	Disposition	2023-09-28	1,780,317	$0.16	0	No	4	S	Indirect	By CRG Partners III ? Parallel Fund ?A? L.P.
Common Stock	Disposition	2023-09-28	571,796	$0.16	0	No	4	S	Indirect	By CRG Partners III (Cayman) Unlev AIV I L.P.
Common Stock	Disposition	2023-09-28	1,937,852	$0.16	0	No	4	S	Indirect	By CRG Partners III (Cayman) Lev AIV I L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By CRG Partners III L.P.
No	4	S	Indirect	By CRG Partners III ? Parallel Fund ?A? L.P.
No	4	S	Indirect	By CRG Partners III (Cayman) Unlev AIV I L.P.
No	4	S	Indirect	By CRG Partners III (Cayman) Lev AIV I L.P.
No	4	S	Indirect	By CRG Partners III L.P.
No	4	S	Indirect	By CRG Partners III ? Parallel Fund ?A? L.P.
No	4	S	Indirect	By CRG Partners III (Cayman) Unlev AIV I L.P.
No	4	S	Indirect	By CRG Partners III (Cayman) Lev AIV I L.P.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.17 to $0.2178, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.15 to $0.175, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.